Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000357501 | SCV000330538 | likely pathogenic | not provided | 2023-08-08 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate R122L results in increased phosphorylation of MEK and ERK1/2 compared to wild-type (Berger et al., 2014); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24469055, 35353015, 34887308) |
Invitae | RCV001037285 | SCV001200691 | pathogenic | Noonan syndrome 8 | 2022-02-08 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects RIT1 function (PMID: 24469055). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RIT1 protein function. This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 122 of the RIT1 protein (p.Arg122Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of RIT1-related conditions (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 280609). |
Center for Medical Genetics and Molecular Medicine, |
RCV002051722 | SCV001950189 | likely pathogenic | Megalencephaly-capillary malformation-polymicrogyria syndrome; Noonan syndrome 8 | 2021-09-30 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001813444 | SCV002060858 | uncertain significance | Noonan syndrome and Noonan-related syndrome | 2017-06-14 | criteria provided, single submitter | clinical testing |